A new drug is marking a Major Milestone in slowing the impacts of Alzheimer’s disease. The drug, Lecanemab, reduces memory decline in Alzheimer’s patients, as shown in its recent trial. Lecanemab is given to patients every two weeks. The drug clears a protein called amyloid, that builds up in the brains of people with Alzheimer’s. Amyloid is believed to be a key cause of the disease. Alzheimer’s patients are currently given other drugs to help manage their symptoms. However, none of these drugs change the trajectory of the disease.  In a trial for the new Lecanemab drug, a total of […]

The story New Drug Marks Major milestone in slowing Alzhemier’s as seen on Thaiger News.